| Name | Title | Contact Details |
|---|---|---|
Anthony Vigilante |
Managing Director, Head of Global Information Technology and Information Security | Profile |
Cornerstone Investment Partners is a Atlanta, GA-based company in the Financial Services sector.
Monarch Alternative Capital is one of the leading companies in the Financial Services sector.
Hilliard Lyons has insights & ideas to help you move from where you are to where you want to go. Founded in 1854 on the simple premise of putting our clients first, Hilliard Lyons provides the complete spectrum of wealth management resources needed to navigate todays complex markets. Central to our mission are the personal relationships that our Financial Consultants forge with our clients, backed by industry research expertise, advanced technology, and innovative approaches to financial planning, estate planning, cash management, lending, business succession, and personal investing. Across seven generations, thousands of individuals, families, and business owners have entrusted their financial futures to Hilliard Lyons. We are single-minded in our commitment to help manage our clients` wealth. As a result, we consistently enjoy top ratings in client satisfaction. Call us today at (800) 444-1854 or visit www.hilliard.com so we can put our experience to work for you, just as we have done successfully for generations of clients. Securities and Advisory Services are offered by J.J.B. Hilliard, W.L. Lyons, LLC (Hilliard Lyons), a Registered Broker Dealer and Investment Advisor, Member NYSE/FINRA/SIPC. Trust Services are offered through our affiliate, Hilliard Lyons Trust Company, LLC. The information on this site is not intended to be used as the primary basis of investment decisions. It is for informational purposes only and is not a representation by us or an offer or a solicitation of an offer to sell or buy any security. Furthermore, this site has been published in the United States for residents of the United States. It is not intended for use by or to provide information to investors outside of the United States.
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.
Adjuvant was established to scale the impact investment model developed at the Global Health Investment Fund (GHIF).